BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 47.23
0.00 (0.00%)
At close: Oct 10, 2025
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €9.13 billion as of October 10, 2025. Its market cap has increased by 120.95% in one year.
Market Cap
9.13B
Enterprise Value
10.08B
Revenue
200.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
€47.23
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 9.13B, an increase of 212.46%. That is a compound annual growth rate of 19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 9.13B | 82.19% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | 7.13B | 84.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 97.20B |
| Intesa Sanpaolo | 95.74B |
| Enel SpA | 84.55B |
| Ferrari | 61.24B |
| Assicurazioni Generali | 50.22B |
| Eni S.p.A. | 46.64B |
| Leonardo S.p.a. | 31.98B |
| Poste Italiane | 26.58B |